AstraZeneca Will Appeal Alabama Medicaid Ruling

Law360, New York (June 20, 2008, 12:00 AM EDT) -- Pharmaceutical giant AstraZeneca LP has said that it will appeal to the Alabama Supreme Court a judgment against the company in a Medicaid drug pricing suit filed by the state of Alabama, despite a state judge's decision to lower the damages from $215 million to $160 million.

“AstraZeneca is pleased that Judge Price reduced the punitive damages award as required by Alabama law,” AstraZeneca spokesman Tony Jewell said on Friday. “However, we are disappointed that Judge Price did not set aside the jury's verdict in its...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.